Cytomegalovirus Retinitis After Fluocinolone Acetonide (Retisert™) Implant

American Journal of Ophthalmology

Volumn 143, Issue 2, 2007, Pages 334-335

  Ufret Vincenty, Rafael L ^a   Singh, Rishi P ^a   Lowder, Careen Y ^a   Kaiser, Peter K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOCINOLONE ACETONIDE; FOSCARNET; GANCICLOVIR;

AGED; ARTICLE; BEHCET DISEASE; CASE REPORT; HUMAN; IMPLANT; MALE; PRIORITY JOURNAL; RETINITIS; TREATMENT FAILURE; UVEITIS;

AGED; ANTIVIRAL AGENTS; BEHCET SYNDROME; CYTOMEGALOVIRUS RETINITIS; DRUG IMPLANTS; FLUOCINOLONE ACETONIDE; FOSCARNET; GANCICLOVIR; GLUCOCORTICOIDS; HUMANS; IMMUNOCOMPROMISED HOST; MACULAR EDEMA, CYSTOID; MALE; RETROSPECTIVE STUDIES; UVEITIS;

EID: 33846376130     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.09.020     Document Type: Article

References (4)

1. Griffiths P. Cytomegalovirus infection of the central nervous system. Herpes 11 (2004) S95A-S104A
2. Kuo I.C., Kempen J.H., Dunn J.P., et al. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol 138 (2004) 338-346
3. Crippa F., Corey L., Chuang E.L., et al. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation. Clin Infect Dis 32 (2001) 214-219
4. Saidel M.A., Berreen J., and Margolis T.P. Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient. Am J Ophthalmol 140 (2005) 1141-1143